Our website has been redesigned.
IRAnnouncement of capital increase through third-party equity allotment: Accelerating global development of innovative medical devices - part 2
IRAnnouncement of capital increase through third-party equity allotment: Accelerating global development of innovative medical devices - part 1
News ReleaseAdriakaim, Inc. wins the “Grand Prix” at the 2nd MEDTECH Innovation Symposium & Pitch” event sponsored by LINK-J.
News ReleaseAdriakaim, Inc. was selected to be part of the 2019 (4Q) Tokyo Advanced Medical Devices Acceleration Project (AMDAP).
News ReleaseAdriakaim, Inc. was selected to receive support as part of the 2019 Kawasaki Deep Tech Accelerator (R&D venture company growth promotion initiative) by Kawasaki City.
News ReleaseAdriakaim, Inc.’s R&D proposal has been adopted by the Japan Agency for Medical Research and Development (AMED) 2019 3Q/4Q Industry-Academia Collaboration Program for Medical Innovation (ACT-M)”.
Adriakaim, Inc. announces an increase in its total capital to 13.5 million JPY through a third-party equity allotment.
Adriakaim, Inc. establishes its corporate entity